Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
EPS (Diluted)
Beijing Tong Ren Tang Chinese Medicine Co Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
|
EPS (Diluted)
HK$0
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
EPS (Diluted)
HK$0
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
23%
|
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
EPS (Diluted)
¥1
|
CAGR 3-Years
39%
|
CAGR 5-Years
30%
|
CAGR 10-Years
16%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-37%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
EPS (Diluted)
HK$0
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
EPS (Diluted)
$0
|
CAGR 3-Years
42%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Glance View
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 745 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
See Also
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's EPS (Diluted)?
EPS (Diluted)
0.6
HKD
Based on the financial report for Dec 31, 2024, Beijing Tong Ren Tang Chinese Medicine Co Ltd's EPS (Diluted) amounts to 0.6 HKD.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
6%
Over the last year, the EPS (Diluted) growth was -8%. The average annual EPS (Diluted) growth rates for Beijing Tong Ren Tang Chinese Medicine Co Ltd have been -6% over the past three years , -2% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet